Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trientine tetrahydrochloride

EU orphan designation number: EU/3/15/1471   
Active ingredient: Trientine tetrahydrochloride
Indication: Treatment of Wilson’s disease
Sponsor: GMP-Orphan SA
Pépinière Paris Santé Cochin, 27-29 rue Faubourg Saint-Jacques, 75014 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/001/15 (2015)2040 of 19/03/2015
20/07/2015 Change of name and/or address of sponsor
24/01/2017 Change of name and/or address of sponsor